Applied Cells is pleased to announce a collaboration with SHENTEK to integrate fast QC release solution with Applied Cells’ GoFast™ CAR-T manufacturing workflow on the MARS® platforms. GoFast™ CAR-T is Applied Cells’ advanced rapid CAR-T manufacturing workflow designed to support
We are thrilled to announce that we’ve been awarded U.S. Patent No. 12,595,460 B2, for the Method and Apparatus for Producing CAR-T Cells. The newly issued patent reinforces our innovation mission in cell therapy manufacturing and supports the company’s GoFast
We are thrilled to share that the MARS® platform was showcased at the ceremonial opening of the new Centre of Excellence CREATIC facilities in Brno at Masaryk University’s Faculty of Medicine on April 8, 2026. The opening of
Applied Cells is pleased to announce the expansion of the MARS® Ingenuity™ line with the addition of CD34 Nanobeads, TCR α/β Nanobeads, and CD56 Nanobeads, now available in both RUO and GMP formats. Designed for use on the MARS® Bar
Santa Clara, California, and Bengaluru, India, January 13, 2026. Applied Cells Inc. announced today a strategic collaboration framework with Immuneel Therapeutics Private Limited to jointly evaluate the application of Applied Cells’ MARS® Atlas platform and GoFast™ CAR-T workflow for future
We’re excited to announce another significant milestone — Applied Cells has officially submitted a Type II Master File (MAF) for the MARS® Bar system to the U.S. Food and Drug Administration (FDA), under the Center for Biologics Evaluation and Research
